Paclitaxel for progressive basal cell carcinoma Ramón Barceló, MD, PhD, Ainhoa Viteri, MD, Alberto Muñoz, MD, Aitziber Gil-Negrete, MD, Itziar Rubio, MD, Guillermo López-Vivanco, MD, PhD Journal of the American Academy of Dermatology Volume 54, Issue 2, Pages S50-S52 (February 2006) DOI: 10.1016/j.jaad.2005.07.036 Copyright © 2006 American Academy of Dermatology, Inc. Terms and Conditions
Fig 1 Pretreatment appearance (A) and response after 6 cycles of paclitaxel (B) for first patient. Pretreatment (C) and response after 5 cycles of cisplatin and paclitaxel (D) on thoracic computed tomography scan of second patient. Journal of the American Academy of Dermatology 2006 54, S50-S52DOI: (10.1016/j.jaad.2005.07.036) Copyright © 2006 American Academy of Dermatology, Inc. Terms and Conditions